Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04575688
Other study ID # 19-06453-FB
Secondary ID
Status Enrolling by invitation
Phase Phase 4
First received
Last updated
Start date July 13, 2021
Est. completion date July 2025

Study information

Verified date October 2023
Source Campbell Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to determine the effectiveness and safety of two standard of care perioperative procedures for controlling pain following ankle and hindfoot osteotomy or fusion or ankle fracture repair.


Description:

This is a prospective, randomized, controlled research study of two perioperative standards of care for managing post operative pain. The first standard of care procedure is the periarticular injection; the second is the popiteal block.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date July 2025
Est. primary completion date July 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Ankle or hindfoot osteotomy or ankle fracture repair - Surgery scheduled at Campbell Surgery Center (1410 Brierbrook Road, Germantown, TN 38138) - 18-80 years of age - ASA I-III with medical clearances as needed - Fluent ub verbal and written English - Willing and able to comply with study instruction and commit to all follow-up visits for theduration of the study - Willing and able to provide written consent Exclusion Criteria: - Diagnosed with chronic pain syndrome - History of allergic reactions to lidocaine, marcaine, Experal, bupivicaine, or other injectable anesthetic agents - Injury associated with workers' compensation - Surgery to be performed at a hospital - Diagnosed with peripheral neuropathy - Hbg A1C is > 7 mg/dl in diabetic patients only - Long term (chronic) preoperative narcotic usage

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Exparel
Exparel will be administered by periarticular injection to patients undergoing hindfoot osteotomy or fusion, ankle osteotomy or fusion, or ankle fracture repair.
Bupivicaine
Bupivicaine will be administered by popliteal block to patients undergoing hindfoot osteotomy or fusion, ankle osteotomy or fusion, or ankle fracture repair.

Locations

Country Name City State
United States A Germantown Tennessee

Sponsors (1)

Lead Sponsor Collaborator
Campbell Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 3
Primary Evidence of motor block Patient reported yes/no answer to survey question: "Are you able to wiggle your toes?" Postoperative hour 3
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 6
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 12
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 24
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 36
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 48
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative hour 72
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative week 2
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative week 4-6
Primary Visual Analog Score Patient reported pain score from zero to ten where zero is no pain and ten is the most pain Postoperative week 12
Secondary Document pain medication prescribed immediately after surgery Pain medication prescribed immediately after the surgery will be documented in the research record. This is a descriptive data point to capture the incidence of narcotics prescribed immediately after surgery, to include opiate name, dose, and number of pills prescribed. Immediately after surgery
Secondary Satisfaction with pain control: survey question Patient reported 7-point Likert scale answer to survey question: "How satisfied are you with your pain control?" 1 = very dissatisfied, 2 = dissatisfied, 3 = moderately dissatisfied, 4 = neutral, 5 = moderately satisfied, 6 = satisfied, 7 = very satisfied. Postoperative week 2
Secondary Neuralgia symptoms: survey question Patient reported yes/no answer to survey question: "Have you had any signs of neuralgia, such as persistent numbness, tingling, or increased sensitivity in your foot or ankle that you feel is not at the surgical location?" 1 = yes, I have had signs of neuralgia; 2 = no, I have not had signs of neuralgia. Postoperative week two
Secondary Pill count Patient reported fill-in-the-blank answer to survey question: "Total number of pain pills taken during this time." Postoperative week 2
Secondary Document pain medication prescribed at postoperative week 2 Pain medication prescribed at postoperative week 2 will be documented in the research record. This is a descriptive data point to capture the incidence of narcotics prescribed at postoperative week 2, to include opiate name, dose, and number of pills prescribed. Postoperative week 2
Secondary Satisfaction with pain control: survey question Patient reported 7-point Likert scale answer to survey question: "How satisfied are you with your pain control?" Patient reported 7-point Likert scale answer to survey question: "How satisfied are you with your pain control?" 1 = very dissatisfied, 2 = dissatisfied, 3 = moderately dissatisfied, 4 = neutral, 5 = moderately satisfied, 6 = satisfied, 7 = very satisfied. Postoperative week 6
Secondary Neuralgia symptoms: survey question Patient reported yes/no answer to survey question: "Have you had any signs of neuralgia, such as persistent numbness, tingling, or increased sensitivity in your foot or ankle that you feel is not at the surgical location?" 1 = yes, I have had signs of neuralgia; 2 = no, I have not had signs of neuralgia. Postoperative week 6
Secondary Pill count Patient reported fill-in-the-blank answer to survey question: "Total number of pain pills taken during this time." Postoperative week 6
Secondary Document pain medication prescribed at postoperative week 6 Pain medication prescribed at postoperative week 6 will be documented in the research record. This is a descriptive data point to capture the incidence of narcotics prescribed at postoperative week 6, to include opiate name, dose, and number of pills prescribed. Postoperative week 6
Secondary Satisfaction with pain control: survey question Patient reported 7-point Likert scale answer to survey question: "How satisfied are you with your pain control?" Patient reported 7-point Likert scale answer to survey question: "How satisfied are you with your pain control?" 1 = very dissatisfied, 2 = dissatisfied, 3 = moderately dissatisfied, 4 = neutral, 5 = moderately satisfied, 6 = satisfied, 7 = very satisfied. Postoperative week 12
Secondary Neuralgia symptoms: survey question Patient reported yes/no answer to survey question: "Have you had any signs of neuralgia, such as persistent numbness, tingling, or increased sensitivity in your foot or ankle that you feel is not at the surgical location?" 1 = yes, I have had signs of neuralgia; 2 = no, I have not had signs of neuralgia. Postoperative week 12
Secondary Pill count Patient reported fill-in-the-blank answer to survey question: "Total number of pain pills taken during this time." Postoperative week 12
Secondary Document pain medication prescribed at postoperative week 12 Pain medication prescribed at postoperative week 12 will be documented in the research record. This is a descriptive data point to capture the incidence of narcotics prescribed at postoperative week 12, to include opiate name, dose, and number of pills prescribed. Postoperative week 12
See also
  Status Clinical Trial Phase
Completed NCT01229696 - Continuous Popliteal Nerve Blocks: Effect of Perineural Catheter Tip Location Relative to the Sciatic Nerve Bifurcation on Postoperative Analgesia Phase 4
Completed NCT01049906 - Popliteal Sciatic Nerve Block Catheter Placement for Foot Surgery N/A
Terminated NCT05354791 - Pre-post Spinal Popliteal Block
Terminated NCT01325012 - Ultrasound-Guided Continuous Sciatic Nerve Blocks: Popliteal Versus Subgluteal Catheters Phase 4
Enrolling by invitation NCT05425979 - Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks Phase 4
Terminated NCT01615939 - A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block Phase 4
Enrolling by invitation NCT06465992 - Liposomal Bupivacaine With Dexamethasone for Foot Surgery Phase 4
Completed NCT05368012 - MIDCAB (Mid-Calf Block) for Foot Surgery Phase 4
Recruiting NCT01546077 - Placement of Perineural Catheters in the Popliteal Region Phase 4
Recruiting NCT06309381 - Influence of Sensory Block Duration on Rebound Pain After Outpatient Foot Surgery Under Popliteal Sciatic Nerve Block.
Completed NCT04134962 - Evaluation of a New Tool for Measuring Hindfoot Alignment Under Load and in 3D.
Enrolling by invitation NCT04872322 - Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery Phase 3